CompuGroup Medical SE & Co. KGaA (CMPUY)
OTCMKTS
· Delayed Price · Currency is USD
24.63
-0.01 (-0.02%)
May 21, 2025, 4:00 PM EDT
CMPUY Revenue
CompuGroup Medical SE & Co. KGaA had revenue of 295.44M EUR in the quarter ending March 31, 2025, with 0.77% growth. This brings the company's revenue in the last twelve months to 1.19B, down -2.55% year-over-year. In the year 2024, CompuGroup Medical SE & Co. KGaA had annual revenue of 1.19B, down -3.39%.
Revenue (ttm)
1.19B EUR
Revenue Growth
-2.55%
P/S Ratio
1.01
Revenue / Employee
134.83K EUR
Employees
8,815
Market Cap
1.30B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.19B | -41.60M | -3.39% |
| Dec 31, 2023 | 1.23B | 53.10M | 4.52% |
| Dec 31, 2022 | 1.17B | 112.11M | 10.55% |
| Dec 31, 2021 | 1.06B | 193.49M | 22.26% |
| Dec 31, 2020 | 869.21M | 98.78M | 12.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| BioStem Technologies | 332.45M |
CompuGroup Medical SE & Co. KGaA News
- 5 months ago - CVC Capital Partners considering takeover of CompuGroup Medical: report - Seeking Alpha
- 5 months ago - CVC In Talks to Take German Software Firm CompuGroup Private - BNN Bloomberg